|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 600 Pennsylvania Ave, SE |
Address2 | Suite 400 |
| City | WASHINGTON |
State | DC |
Zip Code | 20003 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 38814-12
|
||||||||
|
6. House ID# 325310000
|
||||||||
| TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Emily Kowalski |
Date | 7/17/2020 3:31:24 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BAN
16. Specific lobbying issues
Group letter to support H.R. 5332, the Protecting Your Credit Score Act of 2020, (Gottheimer (NJ) (Passed House.)
Group letters to support debt collection provisions of Section 110402 and 110601 of the House-passed HEROES Act, H.R. 6800, restricting the collection of consumer and small business debt. That section gives consumers and small businesses that are facing mounting debts a path to recovery. Urge its inclusion in next COVID stimulus package.
Submitted Comments to Request for Information from Taskforce on Federal Consumer Financial Law, Docket No. CFPB-2020-0013.
Group letters to Urge Congressional leaders and OMB to mandate that Treasury Secretary and Federal Reserve Board fully comply with Coronavirus Aid, Relief, and Economic Security Act (CARES Act, Pub. L. 116-136) disclosure and transparency requirements and mechanisms, especially the provisions establishing the Pandemic Response Accountability Committee (PRAC, 15010 and 15011).
Briefed House Financial Services Committee staff (at their request) on our latest findings on pandemic's impact on number and types of consumer complaints in the CFPB database, particularly its impact on homeowners and mortgages.
Group letter to Urge Congressional leaders to include include S1581 (Merkley-OR)/HR 6470 (Porter-CA) the Medical Debt Relief Act of 2019 in the next COVID-19 relief package. The reforms in the Medical Debt Relief Act are urgently needed to allow American families to access the health care they need without further straining their finances during this public health crisis.
Group letter to urge CFPB Director to suspend all regulatory actions unrelated to COVID19 and take more steps to better protect consumers during pandemic, instead of loosening enforcement on financial firms.
Group letter to urge CFPB Director to suspend actions to weaken Payday Lending and Car Title Loan Regulation, based on leak of internal whistleblower report.
Group letter to support S3913 (Cortez-Masto-NV) The End Double Taxation of Successful Consumer Claims Act to correct 2017 tax reform error that harms consumer-plaintiffs and their attorneys by requiring both to pay taxes on same amount.
Group letter to CFPB Director urging her to cancel Request for Information sent by Taskforce on Federal Consumer Financial Law, Docket No. CFPB-2020-0013.
Sent group letter to OCC opposing its joint rulemaking with OCC to weaken the important Community Reinvestment Act. The Community Reinvestment Act was intended to curb redlining and racial discrimination, and to make access to credit more equitable. Notice of Proposed Rulemaking, Community Reinvestment Act Regulations Docket No: OCC-2018-0008 and RIN 3064-AF22.
Joined consumer and banking industry organizations in letter to urge Congressional leaders at the soonest possible opportunity to clarify that economic impact payments responding to this public health emergency are exempt from otherwise legally binding garnishment orders.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Federal Deposit Insurance Corporation (FDIC), Federal Trade Commission (FTC), Treasury - Dept of, Federal Reserve System, Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Edmund |
Mierzwinski |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Support pro-public health, pro-democracy, pro-consumer, and pro-environment provisions in House COVID-19 stimulus package (H.R.6800) and Senate COVID-19 stimulus package.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Bart |
Johnsen-Harris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
Opposed anti- Right to Repair provisions in the National Defense Authorization Act in the Senate.
Urged leadership of Senate Commerce Committee not to schedule a confirmation vote on and more generally to oppose the nomination of former chemical industry lobbyist Nancy Beck to chair the U.S. Consumer Product Safety Commission. Conducted general outreach activities to Congress on this matter.
Joined coalition letter to FTC urging it to withhold final consent to the merger of prescription drug companies Abbvie and Allergan (AbbVie and Allergan; File No. 191 0169).
Submitted group comment to US DOT on Defining Unfair or Deceptive Practices in Airlines and Ticketing Agents, Docket No. DOT-OST-2019-0182.
Sent civil society letter to House Judiciary Committee leaders opposing efforts by U.S. Chamber of Commerce to demand sweeping business immunity from COVID19-related claims by consumers or workers.
Sent consumer group letter to Congressional leaders opposing efforts by U.S. Chamber of Commerce to demand sweeping business immunity from COVID19-related claims by consumers or workers.
Sent civil society letter to Congressional leaders opposing efforts by U.S. Chamber of Commerce to demand sweeping business immunity from COVID19-related claims by consumers or workers.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Consumer Product Safety Commission (CPSC), Federal Trade Commission (FTC), Transportation - Dept of (DOT)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Edmund |
Mierzwinski |
|
|
|
Katie |
Murtha |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ROD
16. Specific lobbying issues
Support pro-environment provisions in House FY2021 surface transportation bill (H.R.2).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Bart |
Johnsen-Harris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code WAS
16. Specific lobbying issues
Support Break Free From Plastic Pollution Act (H.R.5845 and S.3263).
Oppose RECOVER Act (H.R.5115).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Bart |
Johnsen-Harris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Support provisions to fund FDAs priority action to improve antibiotic stewardship in veterinary settings in House FY2021 Agriculture/FDA appropriations bill and Senate FY2021 Agriculture/FDA appropriations bill.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Bart |
Johnsen-Harris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
Supported dedicated funding in the appropriations bill to meet the current date set for duration limits for antibiotic use in farm animals.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katie |
Murtha |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRA
16. Specific lobbying issues
Support increasing public transportation, bike and walk lanes, and public transportation in the Invest Act.
Support funding for the USPS.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katie |
Murtha |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Supported the Medical Supply Transparency and Delivery Act, which would establish central, transparent coordination of the medical supply chain.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Wellington |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |